Global medical dermatology leader aims to more
effectively engage with medical communities and advance new
treatments that are expected to improve patients' quality of
life
PLEASANTON, Calif., April 27,
2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV)
today announced that it has expanded its partnership with LEO
Pharma, a global leader in medical dermatology, to drive relevant
discussions with the scientific community using Veeva Link for Key
People, a real time intelligence application from the Veeva Link
family of data products. Leveraging Link for Key People
enables LEO Pharma's medical and sales teams to improve engagement
efforts with medical experts in the dermatology
community.
"As we work to advance the standard of care in medical
dermatology, it's crucial our teams have the latest insights from
scientific, digital, and clinical leaders around the world," said
Joshua Corriveau, senior director of
global field medical excellence at LEO Pharma. "As we innovate in
medical dermatology, we need accurate, timely data on the experts
who are at the forefront of related research and development. Link
for Key People will help us deepen relationships with known experts
and identify new experts to foster scientific exchange that
advances patient care."
With plans to launch new treatments every two to three years,
LEO Pharma's medical affairs team plays a vital role in engaging
with scientific leaders globally. Through a nuanced understanding
of each expert, they can enrich in-person and digital engagements
in the evolving healthcare ecosystem. Link is seamlessly
integrated with Veeva CRM, delivering key insights across a range
of sources, including activity from both global and local medical
congresses, clinical trials, and digital engagement.
"Considering LEO Pharma's rapid pace of clinical innovation,
it's no surprise the company's medical and commercial teams are
leading the way in precision engagement," said Kilian Weiss, general manager for Veeva Link.
"By leveraging our real-time customer intelligence to understand
key leaders' scientific sentiment and professional networks, LEO
Pharma's medical and commercial personnel can effectively engage
key people to improve patient health and their quality of
life."
The addition of Link for Key People builds on LEO Pharma's use
of Veeva Commercial Cloud, including solutions
for multichannel engagement and
commercial and medical content management, as well as its
commitment as an early adopter of Veeva's digital trials
platform. To learn more about how Link for Key People helps
biopharmas better understand the full impact of medical activities,
identify new experts and healthcare providers to connect with, and
drive more relevant, coordinated engagements, visit
veeva.com/VeevaLink.
Veeva Link is part of Veeva Data Cloud, a suite of data products
built on a common architecture. For more information, see the Veeva
Summit keynotes on-demand at veeva.com/SummitKeynotes and
veeva.com/DataCloudKeynote. Life sciences industry professionals
can also register for the Veeva Commercial Summit for sales,
medical, and marketing in Boston
on May 5.
Additional Information
For more on Veeva Link, visit:
veeva.com/VeevaLink
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: twitter.com/veevasystems
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
pharmaceutical companies to emerging biotechs. As a Public Benefit
Corporation, Veeva is committed to balancing the interests of all
stakeholders, including customers, employees, shareholders, and the
industries it serves. For more information, visit veeva.com.
Veeva Forward-looking Statements
This release contains
forward-looking statements regarding Veeva's products and services
and the expected results or benefits from use of our products and
services. These statements are based on our current expectations.
Actual results could differ materially from those provided in this
release and we have no obligation to update such statements. There
are numerous risks that have the potential to negatively impact our
results, including the risks and uncertainties disclosed in our
filing on Form 10-K for the period ended January 31, 2022, which you can find here (a
summary of risks which may impact our business can be found on
pages 13 and 14), and in our subsequent SEC filings, which you can
access at sec.gov.
Contact:
|
Deivis Mercado
Veeva Systems
925-226-8821 deivis.mercado@veeva.com
|
Kiran May
Veeva Systems +44-796-643-2912 kiran.may@veeva.com
|
Henrik
Heskjaer
LEO Pharma
+45-314-061-80
HDTDK@leo-harma.com
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/leo-pharma-leverages-veeva-link-for-key-people-to-expand-engagement-with-scientific-experts-301533997.html
SOURCE Veeva Systems